Trump Nominates Dr. Erica Schwartz to Lead Centers for Disease Control and Prevention

President Donald Trump has announced the nomination of Dr. Erica Schwartz, a retired U.S. Public Health Service vice admiral and former deputy surgeon general, to serve as director of the Centers for Disease Control and Prevention. The announcement follows weeks of speculation and reporting that identified Dr. Schwartz as the president’s leading candidate for the high-profile post overseeing the nation’s top public health agency.

Dr. Schwartz brings a lengthy federal public health résumé to the nomination. A physician specializing in obstetrics and gynecology, she rose through the ranks of the U.S. Public Health Service Commissioned Corps to become a vice admiral, one of only a handful of women to have achieved that rank. During the first Trump administration she served as deputy surgeon general under Dr. Jerome Adams, where she helped coordinate federal responses to the opioid epidemic, maternal health initiatives, and early pandemic preparedness efforts. Prior to that, she held the top medical post at the U.S. Coast Guard, overseeing medical readiness for tens of thousands of service members and their families.

The nomination arrives at a moment of significant upheaval at the CDC. The Atlanta-based agency, which employs roughly 13,000 people and operates on an annual budget of more than $9 billion, has seen a rapid succession of directors and acting directors since the start of the second Trump administration. Susan Monarez, who was confirmed earlier this year, was removed from the role amid public clashes over vaccine policy, and the agency has since navigated budget cuts, restructuring proposals advanced by Health and Human Services Secretary Robert F. Kennedy Jr., and an exodus of senior career scientists. The director’s chair sits at the center of debates over vaccine recommendations, outbreak response, and the agency’s relationship with the Advisory Committee on Immunization Practices, whose membership was overhauled earlier this year.

If confirmed, Dr. Schwartz would inherit an agency grappling with declining childhood vaccination rates, resurgent measles outbreaks in several states, ongoing concerns about H5N1 avian influenza in dairy cattle and farm workers, and persistent questions about the CDC’s data systems and communication infrastructure following the COVID-19 pandemic. She would also be expected to implement administration priorities on chronic disease, food additives, and environmental health that Secretary Kennedy has made central to the department’s agenda. The Senate Health, Education, Labor and Pensions Committee is expected to schedule confirmation hearings in the coming weeks, where lawmakers are likely to probe her views on vaccine policy, pandemic preparedness, and the proper scope of federal public health authority.